4.4 Article

Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease

Journal

NATURE REVIEWS NEUROSCIENCE
Volume 12, Issue 2, Pages 67-72

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrn2967

Keywords

-

Categories

Funding

  1. University of Sydney
  2. National Health & Medical Research Council (NHMRC)
  3. Australian Research Council (ARC)
  4. J.O. & J.R. Wicking Trust

Ask authors/readers for more resources

Amyloid-beta and tau are the two hallmark proteins in Alzheimer's disease. Although both amyloid-beta and tau have been extensively studied individually with regard to their separate modes of toxicity, more recently new light has been shed on their possible interactions and synergistic effects in Alzheimer's disease. Here, we review novel findings that have shifted our understanding of the role of tau in the pathogenesis of Alzheimer's disease towards being a crucial partner of amyloid-beta. As we gain a deeper understanding of the different cellular functions of tau, the focus shifts from the axon, where tau has a principal role as a microtubule-associated protein, to the dendrite, where it mediates amyloid-beta toxicity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available